Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

Medtronic has landed on a new brand for the planned spinout of its diabetes division, and it didn’t have to look very far. | ...

Image courtesy of Medtronic] The soon-to-be-separated Medtronic (NYSE: MDT) + Diabetes unit has a new — yet familiar — name, ...

Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump. Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted ...

The M&A news came as Medtronic also released an earnings report summing up its fiscal year 2023, which ended April 28. Altogether, the company took in more than $31.2 billion for the year. Though ...

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

For many, a partnership between Abbott and Medtronic, two medtech giants and frequent competitors, would have seemed unlikely ...

Medtronic has issued an urgent medical device correction letter warning users of the MiniMed 600 and 700 series of insulin pumps of an increased risk for shorter-than-expected battery life ...

GALWAY, Ireland, Oct. 4, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global ...

Trefis estimates Medtronic’s Q4 fiscal 2023 total revenues to be around $8.2 billion, reflecting a low single-digit y-o-y rise but marginally below the $8.3 billion consensus estimate.

Medtronic has issued an “Urgent Medical Device Correction” about the accuracy of insulin pump delivery during changes in air pressure, such as airplane takeoffs and landings.

Medical-device maker Medtronic MDT-0.13 % decrease; red down pointing triangle plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a ...